E-LIB Suche - Ergebnisse für: Mansfield, S. D.

1

2MO Amivantamab plus chemotherapy vs chemotherapy as first-..:

Felip, E. ; Shu, C.A. ; Aguilar, A....
ESMO Open. 9 (2024) - p. 102581 , 2024

Link: https://doi.org/10.1016/..

2

7P Patient-relevant endpoints from PAPILLON: Amivantamab pl..:

Paz-Ares, L. ; Veillon, R. ; Majem, M....
ESMO Open. 9 (2024) - p. 102586 , 2024

Link: https://doi.org/10.1016/..

3

MA17.10 miRNA Signatures In Mesothelioma and their Associat..:

Kosari, F. ; Disselhorst, M. ; Peikert, T....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S165 , 2023

Link: https://doi.org/10.1016/..

4

EP14.04-01 BRCA-Associated Protein-1 (BAP1) Loss and Real-W..:

Smith, C.J. ; Desai, A. ; Hazim, A....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S726-S727 , 2023

Link: https://doi.org/10.1016/..

5

P2.16-03 RYZ101 + Carboplatin + Etoposide + Atezolizumab in..:

Mulvey, C. ; Langdon, R. ; Berilgen, J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S375-S376 , 2023

Link: https://doi.org/10.1016/..

6

EP11.03-26 Real-World Outcomes with Immunotherapy Compared ..:

Parikh, K. ; Leventakos, K. ; Mansfield, A.S....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S631 , 2023

Link: https://doi.org/10.1016/..

7

OA02.04 Phase 1/2 Randomized Trial of Anetumab Ravtansine a..:

Mansfield, A.S. ; Yin, J.V. ; Bradbury, P....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S47 , 2023

Link: https://doi.org/10.1016/..

8

First-line nivolumab plus ipilimumab versus chemotherapy in..:

Peters, S. ; Scherpereel, A. ; Cornelissen, R....
Annals of Oncology. 33 (2022) 5 - p. 488-499 , 2022

Link: https://doi.org/10.1016/..

9

Crizotinib in patients with tumors harboring ALK or ROS1 re..:

Mansfield, A. S. ; Wei, Z. ; Mehra, R....
npj Precision Oncology. 6 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

10

139P The timing, dynamics, and co-occurrence of immune-rela..:

Smith, K.E. ; Pritzl, S. ; Yu, W....
Immuno-Oncology and Technology. 16 (2022) - p. 100251 , 2022

Link: https://doi.org/10.1016/..

11

Safety and efficacy of pralsetinib in RET fusion–positive n..:

Griesinger, F. ; Curigliano, G. ; Thomas, M....
Annals of Oncology. 33 (2022) 11 - p. 1168-1178 , 2022

Link: https://doi.org/10.1016/..

12

EP08.02-037 Small Cell Transformation in a Patient with RET..:

Dimou, A. ; Lo, Y.-C. ; Halling, K..
Journal of Thoracic Oncology. 17 (2022) 9 - p. S414 , 2022

Link: https://doi.org/10.1016/..

13

125P A phase IIa study of the novel immunogenic cell death ..:

Imbimbo, M. ; Ghisoni, E. ; Mulvey, A....
Immuno-Oncology and Technology. 16 (2022) - p. 100237 , 2022

Link: https://doi.org/10.1016/..

14

Adjuvant Radiation Therapy for Pleural Mesothelioma after E..:

Breen, W. ; Garces, Y. ; Olivier, K....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e107-e108 , 2020

Link: https://doi.org/10.1016/..

15

Safety and patient-reported outcomes of atezolizumab, carbo..:

Mansfield, A.S. ; Każarnowicz, A. ; Karaseva, N....
Annals of Oncology. 31 (2020) 2 - p. 310-317 , 2020

Link: https://doi.org/10.1016/..